Loading...

Loading...

FDA Approves Dupixent to Treat Eczema in Young Children
FDA Approves Dupixent to Treat Eczema in Young Children
By Antonio Gozain - Wed, 06/08/2022 - 11:37
Dupixent, Sanofi’s best-selling drug, received FDA approval to treat atopic dermatitis in children aged six months to five years.

Featured content

Most popular